In the last trading session, 1.55 million shares of the Guardant Health Inc (NASDAQ:GH) were traded, and its beta was 1.13. Most recently the company’s share price was $30.68, and it changed around $1.72 or 5.94% from the last close, which brings the market valuation of the company to $3.79B. GH currently trades at a discount to its 52-week high of $37.04, offering almost -20.73% off that amount. The share price’s 52-week low was $15.81, which indicates that the current value has risen by an impressive 48.47% since then. We note from Guardant Health Inc’s average daily trading volume that its 10-day average is 2.95 million shares, with the 3-month average coming to 2.10 million.
Guardant Health Inc stock received a consensus recommendation rating of Buy, based on a mean score of 1.42. If we narrow it down even further, the data shows that 0 out of 22 analysts rate the stock as a Sell; another 7 rate it as Overweight. Among the rest, 1 recommended GH as a Hold, whereas 14 deemed it a Buy, and 0 rated it as Underweight. Guardant Health Inc is expected to report earnings per share of -0.51 for the current quarter.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Guardant Health Inc (NASDAQ:GH) trade information
Instantly GH has showed a green trend with a performance of 5.94% at the end of last trading. The performance over the last five days has remained in the green territory. The rise to weekly highs of 32.26 on recent trading dayincreased the stock’s daily price by 4.9%. The company’s shares are currently up 13.42% year-to-date, but still up 3.20% over the last five days. On the other hand, Guardant Health Inc (NASDAQ:GH) is 47.22% up in the 30-day period. We can see from the shorts that 10.26 million shares have been sold at a short interest cover period of 7.41 day(s).
The consensus price target as assigned by Wall Street analysts is $40, which translates to bulls needing to increase their stock price by 23.3% from its current value. Analyst projections state that GH is forecast to be at a low of $36 and a high of $125.
Guardant Health Inc (GH) estimates and forecasts
Guardant Health Inc share prices are performing particularly well compared to other companies within the same industry. As is evident from the statistics, the company’s shares have risen 23.86 percent over the past six months and at a 55.37% annual growth rate that is well above the industry average of 17.80%. Moreover, analysts have decided to roll up on their fiscal year 2024 revenue estimates. The rating firms predict that it will gain 19.97% in revenue this quarter, and will report a decrease of -19.56% in the next quarter. The year-over-year growth rate is expected to be 28.37%, up from the previous year.
Consensus estimates provided by 20 financial analysts predict the company will bring in an average of 189.02M in revenue for the current quarter. 15 analysts expect Guardant Health Inc to make 190.66M in revenue for the current ending quarter. The company’s sales for the same quarters a year ago were 155.05M and 168.49M respectively. Analysts predict that the company’s current quarter sales will jump, forecast at 21.91%. Forecasts for the next quarter put sales growth at 13.16%.
Looking at the company’s year-over-year earnings, the past five years showed a negative earnings growth rate of -8.88%. Guardant Health Inc earnings are expected to increase by 19.46% in 2024, but the outlook is positive 29.20% per year for the next five years.
GH Dividends
Guardant Health Inc’s next quarterly earnings report is expected to be released in December.
Guardant Health Inc (NASDAQ:GH)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 4.56% of Guardant Health Inc shares, and 104.62% of them are in the hands of institutional investors. The stock currently has a share float of 109.62%. Guardant Health Inc stock is held by 383.0 institutions, with VANGUARD GROUP INC being the largest institutional investor. By 2024-06-30, it held 9.5609% of the shares, which is about 11.64 million shares worth $336.07 million.
BLACKROCK INC., with 9.2332% or 11.24 million shares worth $324.55 million as of 2024-06-30, holds the second largest percentage of outstanding shares.
